MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-24-0009263
Omgene Life Sciences Private Limited - life sciences in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹30.12 Cr
▲ 42% YoY
Net profit · FY 2025
₹2.98 Cr
Net margin 9.9%
EBITDA · FY 2025
₹5.97 Cr
EBITDA margin 19.8%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹26.06 Lakh
Issued & subscribed
Open charges
₹7.12 Cr
Satisfied ₹9.34 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
80
Provident fund records
About Omgene Life Sciences Private Limited
Data last updated:
Omgene Life Sciences Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 17 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2011PTC064483. Its GSTIN is 24AABCO4404G1ZX (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹26.06 Lakh. It is led by directors Lakshmiprasad Sasidharrao Alaparthi and Udaya Sree Lakshmi Prasad Alaparthi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 71 Shilalekh Duplex Near Nandanvan Alkapuri, Vadodara, Gujarat, India – 390007.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.12 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹2.98 Cr (net margin 9.9%) and EBITDA of ₹5.97 Cr (EBITDA margin 19.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 23% over five years.
The company has about 80 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Omgene. As per MCA filings, the company has open charges of ₹7.12 Cr and satisfied charges of ₹9.34 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹1.91 Cr; the latest was in August 2018. Its 3 peer companies in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development) are compared by revenue, 2 larger and 1 smaller; the largest is Flex and Oncology Clinical Research Private Limited with revenue of ₹33.24 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 6 overdue payments to 6 micro and small suppliers.
Omgene Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0009263). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website omgene.com.
Company details
CIN U24230GJ2011PTC064483
Registration Number 064483
Incorporation Date 17 March 2011
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-24-0009263
Key People
Lakshmiprasad Sasidharrao Alaparthi Director Udaya Sree Lakshmi Prasad Alaparthi Director Recognitions & Rankings of Omgene Life Sciences
Contact details
Omgene Life Sciences Private Limited's registered office is in Vadodara, Gujarat. Its website is omgene.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address71 Shilalekh Duplex Near Nandanvan Alkapuri, Vadodara, Gujarat, India – 390007
- IndustryLife Sciences, Biotechnology
To see the full contact details of Omgene Life Sciences Private Limited, buy the company report.
Comprehensive company report
Omgene Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Omgene Life Sciences operates one associated brand: Omgene. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in R&D for lab-scale production of complex APIs and intermediates for patient treatments. | omgene.com |
Business activity
The main business activity of Omgene Life Sciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Omgene Life Sciences Private Limited, buy the company report.
Financials of Omgene Life Sciences Private Limited
FY 2025 filings availableOmgene Life Sciences Private Limited reported revenue of ₹30.12 Cr (up 42% YoY) for FY 2025.
Revenue · FY 2025
₹30.12 Cr ▲ 42%
Net profit · FY 2025
₹2.98 Cr margin 9.9%
EBITDA · FY 2025
₹5.97 Cr margin 19.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 26%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 114%
3 years · compounded
▲ 54%
5 years · compounded
▲ 31%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 42% growth in the latest year. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.98 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.8% | ||||
| Net Profit Margin | 9.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Omgene Life Sciences Private Limited, buy the company report.
Board of directors of Omgene Life Sciences Private Limited
Omgene Life Sciences has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmiprasad Sasidharrao Alaparthi | Director | 17 Mar 2011 | 15 Years 7 Months | Current |
| Udaya Sree Lakshmi Prasad Alaparthi | Director | 17 Mar 2011 | 15 Years 7 Months | Current |
Peer comparison
Omgene Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Flex and Oncology Clinical Research Private Limited | ₹33.24 Cr (FY 2025) | 41.0% | Thiruvananthapuram, Kerala, India | |||
| Perfect Day India Private Limited | ₹33.04 Cr (FY 2025) | -8.0% | Anekal, Karnataka, India | |||
| Omgene Life Sciences Private Limitedthis company | ₹30.12 Cr (FY 2025) | ₹2.98 Cr | 9.9% | 42.0% | 80 | Vadodara, Gujarat, India |
| Hylasco Bio-Technology (India) Private Limited | ₹28.41 Cr (FY 2025) | -2.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Omgene Life Sciences Private Limited, buy the company report.
Auditor
Omgene Life Sciences Private Limited is audited by HARIBHAKTI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARIBHAKTI & CO. | FY 2023 | 118013W |
Shareholding
The shareholding of Omgene Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Omgene Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.12 Cr
Satisfied charges
₹9.34 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jun 2019 | 100274643 | Axis Bank Limited | ₹7.12 Cr | Open | |
| 29 Apr 2022 | 100568373 | Others | ₹3.11 Cr | Satisfied | |
| 29 Apr 2022 | 100568380 | Others | ₹6.23 Cr | Satisfied |
To see the full charge records of Omgene Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Omgene Life Sciences Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹1.91 Cr; the latest was in August 2018.
Total deals
2
Funding rounds
2
Disclosed funding
₹1.91 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2018 | Funding round | ₹1.02 Cr | Investors: 3 individuals |
| Aug 2012 | Funding round | ₹89.2 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Omgene Life Sciences Private Limited has 2 court cases on record: 1 filed by Omgene Life Sciences, 1 filed against it. All cases are disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Income Tax Department Through Officer Jitendra Kumar Income Tax Officer | Disposed |
| High Court, MAHARASHTRA | Court case (COMMP) | Filed by the company against individuals | Disposed |
To see the full case history of Omgene Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Omgene Life Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 6 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Zodiac Life Sciences Private Limited | |||
| Scientific Sales Research Chemicals Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Omgene Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Omgene Life Sciences Private Limited has a workforce of 80 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
80
Active EPFO establishments
1
Employee growth
17.65%
GST
Omgene Life Sciences has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCO4404G1ZX | Gujarat | Active | 01 Jul 2017 |
| 24AABCO4404G2ZW | Gujarat | Active | 22 Aug 2024 |
To see the full GST registrations and return filing status of Omgene Life Sciences Private Limited, buy the company report.
Recent activity
Omgene Life Sciences Private Limited has 6 board changes on record since 2011: 2 appointments and 4 cessations. The latest: Madhavi Thirividhi ceased to be Director on 05 Nov 2019.
AGM
Omgene Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Omgene Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Axis Bank Limited of Rs. 712.00 Lakh registered on 14 Jun 2019 with Charge ID 100274643 was modified on 23 Aug 2024.
Charges
A charge registered on 29 Apr 2022 via Charge ID 100568373 with Others was fully satisfied on 22 Aug 2022.
Charges
A charge registered on 29 Apr 2022 via Charge ID 100568380 with Others was fully satisfied on 22 Aug 2022.
Charges
A charge with Others amounted to Rs. 311.20 Lakh with Charge ID 100568373 was registered on 29 Apr 2022.
Charges
A charge with Others amounted to Rs. 622.50 Lakh with Charge ID 100568380 was registered on 29 Apr 2022.
Ceased
Madhavi Thirividhi ceased to be Director.
Ceased
Rama Krishna Thirividhi ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 712.00 Lakh with Charge ID 100274643 was registered on 14 Jun 2019.
Ceased
Ranjana Sanjay Bhargav ceased to be Director.
Ceased
Murali Krishna Madala ceased to be Director.
3 earlier events are in the company report.
Frequently asked questions
Omgene Life Sciences is an active private limited company based in Vadodara, Gujarat, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 17 March 2011 (15+ years old) and is registered under CIN U24230GJ2011PTC064483.
Omgene Life Sciences has 2 current directors:
- Lakshmiprasad Sasidharrao Alaparthi - Director
- Udaya Sree Lakshmi Prasad Alaparthi - Director
The latest financial statements of Omgene Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Omgene Life Sciences is 24AABCO4404G1ZX, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AABCO4404G2ZW (Gujarat).
The CIN (Corporate Identification Number) of Omgene Life Sciences is U24230GJ2011PTC064483. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Omgene Life Sciences has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.
Omgene Life Sciences was incorporated on 17 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Omgene Life Sciences has 2 deals on record (2 funding rounds), with disclosed funding of ₹1.91 Cr; the latest was in August 2018.
The peers of Omgene Life Sciences by revenue are Flex and Oncology Clinical Research Private Limited, Perfect Day India Private Limited, Hylasco Bio-Technology (India) Private Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development).
Madhavi Thirividhi ceased to be Director on 05 Nov 2019. Rama Krishna Thirividhi ceased to be Director on 05 Nov 2019. Ranjana Sanjay Bhargav ceased to be Director on 04 Sep 2018. Omgene Life Sciences has 6 board changes on record in total.
Yes, Omgene Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-24-0009263).
Omgene Life Sciences has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 6 overdue payments to 6 micro and small suppliers. The latest return was filed on 29 Apr 2024.